Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
CStone announces the clinical data from registrational study of Sugemalimab in stage III non-small cell lung cancer published in The Lancet Oncology 2022-01-15 08:35
CStone announces the registrational clinical study results of sugemalimab in stage IV non-small cell lung cancer published in The Lancet Oncology 2022-01-15 08:31
French Consul General in Guangzhou led a delegation to visit Biosyngen in China-Singapore Guangzhou Knowledge City 2022-01-15 08:00
LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant 2022-01-14 19:18
Crunchfish Gesture Interaction introduction - Deeply intuitive gestures 2022-01-14 19:17
Leapstack Raised Nearly 150 Million Yuan in Series C Round Financing, Catalyzing Transformation of Intelligent Risk Control in Healthcare Insurance 2022-01-14 13:00
EW Nutrition showcases innovative solutions at International Dairy Week 2022 2022-01-14 09:00
Everest Medicines Enters into a Global Licensing Agreement to Develop and Commercialize Singapore's Experimental Drug Development Centre's 3CL Protease Inhibitors as Potentially Best-in-Class COVID-19 Oral Antiviral Treatments Worldwide 2022-01-14 08:00
Dr. Luciana Young Named Vice Chair of Inteleos Board of Directors 2022-01-13 22:48
Ascletis Announces First Patient Dosed in the Phase II Clinical Trial of FASN Inhibitor ASC40 for Treatment of Moderate to Severe Acne 2022-01-13 17:30
Apex Medical Rebrands to Wellell, redefining core values 2022-01-13 16:00
Accuredit Therapeutics and N1 Life Form a Joint Venture Named 'Napoltec', Dedicated to the Development of Therapeutic Drug Delivery Systems and Pressing Ahead Clinical Translation 2022-01-13 13:33
NeuroAiD(TM)II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic treatments and may have a disease modifying effect by delaying disease progression 2022-01-13 12:32
Enrollment Completed in Phase II Clinical Study of KN026 Combined with KN046 2022-01-13 10:46
CStone announces phase 2 GEMSTONE-201 trial met primary endpoint of objective response rate (ORR) in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL) 2022-01-13 08:05
Seegene Unveils Blueprint for the Future of Molecular Diagnostics, Including Open Development Platform at the 40th Annual J.P. Morgan Healthcare Conference 2022-01-13 04:00
Ascend to build HMD plant in China's Jiangsu province 2022-01-12 23:00
Largest Global Health Network Havas Health & You Certified As "Great Place to Work" 2022-01-12 22:31
Dr. Michael Lilly elected to Chair of Inteleos Board of Directors 2022-01-12 22:03
South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine 2022-01-12 20:43
1 244 245 246 247 248 742